Trial | NCT02219399  Report issue

Title

DHA Supplementation and Pregnancy Outcome
Maternal DHA Supplementation and Pregnancy Outcome

  • Phase

    N/A

  • Study Type

    Interventional

  • Status

    Completed No Results Posted

  • Intervention/Treatment

    fish oil ...

  • Study Participants

    871
Supplementation with DHA during pregnancy will increase gestational length and improve cognitive development.
This was a trial of supplementation with DHA during pregnancy to increase gestational length. Subjects were provided with 300 mg, 600 mg or placebo (olive oil) in a randomized design from week 24-26 of pregnancy until delivery. Gestational age, birth weight and birth length data were collected and infants growth at 2 and 4 months and cognitive development at 4 months and 1 year were measured.
Study Started
Jan 31
2001
Primary Completion
Jan 31
2004
Study Completion
Jan 31
2014
Last Update
Aug 18
2014
Estimate

Dietary Supplement 600 mg DHA

Pregnant women were given 600 mg DHA in the last trimester of pregnancy

Dietary Supplement 300 mg DHA

Pregnant women were given 300 mg DHA in the last trimester of pregnancy and through the first 3 months of breastfeeding

Dietary Supplement Placebo

Pregnant women in the control group received placebo of either olive oil or high oleic acid sunflower oil during the study period

300 mg DHA Experimental

300 mg DHA

Placebo Placebo Comparator

olive oil or high oleic acid sunflower oil placebo

600 mg DHA Experimental

600 mg DHA

Criteria 

Inclusion Criteria:

singleton pregnancy
18 years of age or older

Exclusion Criteria:

cervical incompetence
presence of cervical cerclage
placenta previa
intrauterine infection
known substance abuse
multiple fetuses
current pre-eclampsia
preexisting diabetes
No Results Posted